Zobrazeno 1 - 3
of 3
pro vyhledávání: '"So Youn Ro"'
Autor:
Jung Min Kim, Da Hye Kim, Hyo Jeong Park, Hyun Woo Ma, I Seul Park, Mijeong Son, So Youn Ro, Seokmann Hong, Hyo Kyung Han, Soo Jeong Lim, Seung Won Kim, Jae Hee Cheon
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-13 (2020)
Abstract Background Infliximab (IFX), a TNF-α blocking chimeric monoclonal antibody, induces clinical response and mucosal healing in patients with inflammatory bowel disease (IBD). However, systemic administration of this agent causes unwanted side
Externí odkaz:
https://doaj.org/article/ac2a41b54b1e4fe7899683481fa2f441
Autor:
Seokmann Hong, Hyo Kyung Han, So Youn Ro, Hyun Woo Ma, Jae Hee Cheon, I Seul Park, Jung Min Kim, Da Hye Kim, Hyo Jeong Park, Soo Jeong Lim, Seung Won Kim, Mi Jeong Son
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-13 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Infliximab (IFX), a TNF-α blocking chimeric monoclonal antibody, induces clinical response and mucosal healing in patients with inflammatory bowel disease (IBD). However, systemic administration of this agent causes unwanted side effects. Oral deliv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3cb5a213b2b6ae49c6bd402f6305d1
http://link.springer.com/article/10.1186/s12951-020-00693-4
http://link.springer.com/article/10.1186/s12951-020-00693-4
Autor:
Chang-Ho Lee, Kye-Youn Ro
Publikováno v:
Otolaryngology - Head and Neck Surgery. 133:P246-P246
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6651fcdf446ed0e9de1ebaccb01a974a
https://doi.org/10.1016/j.otohns.2005.05.600
https://doi.org/10.1016/j.otohns.2005.05.600